4//SEC Filing
Noci Darlene 4
Accession 0001193125-26-000950
CIK 0001861560other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 4:20 PM ET
Size
10.5 KB
Accession
0001193125-26-000950
Insider Transaction Report
Form 4
Nuvalent, Inc.NUVL
Noci Darlene
Chief Development Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2025-12-30$27.85/sh+4,000$111,400→ 52,034 total - Sale
Class A Common Stock
2025-12-30$99.82/sh−3,358$335,196→ 48,676 total - Sale
Class A Common Stock
2025-12-30$101.22/sh−642$64,983→ 48,034 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-30−4,000→ 114,329 totalExercise: $27.85Exp: 2033-01-06→ Class A Common Stock (4,000 underlying)
Footnotes (4)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2024.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.49 to $100.47, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) of this Form 4.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.84 to $101.76, inclusive.
- [F4]The shares underlying this option have vested or shall vest over the four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
Documents
Issuer
Nuvalent, Inc.
CIK 0001861560
Entity typeother
Related Parties
1- filerCIK 0001862148
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 4:20 PM ET
- Size
- 10.5 KB